Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.24.3
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
shares in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Sep. 30, 2024
Sep. 30, 2023
Operating expenses:        
Research and development $ 3,242,000 $ 4,194,000 $ 10,500,000 $ 10,902,000
General and administrative 1,800,000 1,849,000 4,148,000 4,591,000
Legal settlement (1,600,000) (1,600,000)
Total operating expenses 5,042,000 4,443,000 14,648,000 13,893,000
Loss from operations (5,042,000) (4,443,000) (14,648,000) (13,893,000)
Other income (expense):        
Interest income (expense), net 111,000 320,000 482,000 460,000
Foreign exchange loss (8,000) (42,000) (72,000) (87,000)
Total other expense, net 103,000 278,000 410,000 373,000
Net loss $ (4,939,000) $ (4,165,000) $ (14,238,000) $ (13,520,000)
Net loss per common share, basic $ (0.49) $ (0.41) $ (1.40) $ (1.43)
Net loss per common share, diluted $ (0.49) $ (0.41) $ (1.40) $ (1.43)
Weighted average number of common shares outstanding, basic 10,174 10,153 10,174 9,461
Weighted average number of common shares outstanding, diluted 10,174 10,153 10,174 9,461